Location History:
- Research Triangle Park, NC (US) (2016)
- Boston, MA (US) (2019 - 2023)
Company Filing History:
2 out of 67 
1 out of 8 
1 out of 230 
Years Active: 2016-2023
Title: The Innovative Contributions of Steven Thomas Dock
Introduction
Steven Thomas Dock, an accomplished inventor based in Boston, MA, has made significant strides in the field of biochemistry with a total of four patents to his name. His work focuses on developing therapeutic solutions that address metabolic disorders and related diseases.
Latest Patents
One of Dock's latest patents is centered around glucagon-receptor selective polypeptides and methods of use thereof. This invention pertains to isolated polypeptides that are glucagon-receptor selective analogs and peptide derivatives. These analogs are specifically designed to target the human glucagon receptor, exhibiting enhanced solubility, thermal stability, and favorable physicochemical properties compared to the native endogenous glucagon. This pioneering work further details the methods for utilizing such polypeptides in various therapeutic and diagnostic applications. Notably, these analogs hold promise for treating obesity, diabetes, metabolic disorders, and other related health issues, either independently or in conjunction with other therapeutic peptides.
Career Highlights
Throughout his career, Steven Dock has collaborated with prominent organizations such as Intarcia Therapeutics, Inc. and GlaxoSmithKline Intellectual Property Development Limited. His work in these companies reflects his commitment to advancing scientific research and therapeutic innovations.
Collaborations
In his professional journey, Dock has partnered with esteemed colleagues, including Ved P. Srivastava and Robert Neil Hunter, III. These collaborations have played a crucial role in the successful development and patenting of his inventions, showcasing the power of teamwork in innovation.
Conclusion
Steven Thomas Dock’s contributions to the field of biochemistry through his inventive work with glucagon-receptor selective polypeptides are noteworthy. His patents not only reflect his dedication to addressing critical health challenges but also exemplify the impact of innovation in medical science. As his career progresses, Dock continues to inspire future inventors and researchers with his groundbreaking efforts.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.